RWJ-445380
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RWJ-445380, covering 2011-02-18 to 2011-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis [Phase 2]